Asia Pacific Electrical Stimulation Devices Market
Published On: Aug 2020
Published On: Aug 2020
Sacral Nerve Stimulation (SNS) Devices Segment to Witness Higher CAGR During Forecast Period
According to the latest study on “Asia Pacific Electrical Stimulation Devices Market Forecast to 2027 – COVID-19 Impact and Analysis – by Device Type and Application,” the market was valued at US$ 1,195.6 million in 2019 and is projected to reach US$ 2,506.0 million by 2027; it is expected to grow at a CAGR of 9.9% during 2020–2027. The report highlights trends prevailing in the Asia Pacific electrical stimulation devices market and the factors driving market along with those that act as hindrances.
Based on device type, the Asia Pacific electrical stimulation devices market is segmented into spinal cord stimulation devices, deep brain stimulation devices, vagus nerve stimulation (VNS) devices, sacral nerve stimulation (SNS) devices, gastric electrical stimulation (GES) Devices, transcutaneous electrical nerve stimulation (TENS) devices, and other devices. In 2019, the spinal cord devices segment held a larger share of the market. However, the sacral nerve stimulation devices segment is expected to grow at a faster rate during the forecast period.
The growth of the Asia Pacific electrical stimulation devices market is attributed to the increasing incidences of neurological disorders, growing prevalence of chronic pain, and increasing product awareness. However, the high cost of procedures limits the growth of market in this region.
Boston Scientific Corporation, Medtronic, Abbott, BTL, and DJO Global Inc. are among the leading companies operating in the Asia Pacific electrical stimulation devices market.
The report segments Asia Pacific Electrical Stimulation Devices Market as follows:
By Device Type
By Application
By Country
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
